Nurses should be familiar with PET scan protocol and what to ask patients with lung and bone cancers before administering ...

Given these data, Kirschner, the director of program development at the Cancer Survivorship and Supportive Care Professionals ...

New FDA approvals in July include therapies for NSCLC, relapsed multiple myeloma, liver cancer, and B-cell malignancies.

Explore essential mental health support strategies for older adults with cancer, addressing grief, community resources, and ...

Experienced oncology nurses and APPs can help nurses newer to the field understand who is more at risk of opioid addiction, ...

Panelists discuss how the unprecedented 5-year progression-free survival benefit (60% vs 8%) demonstrated in the CROWN trial ...

Establishing a routine early in treatment helps proactively manage adverse effects associated with CDK4/6 inhibitors, says ...

Oncology Nursing News connects oncology nurses and APPs with updates on therapy advances, side effect management, and patient ...

The addition of retifanlimab to chemotherapy increased progression-free survival in patients with advanced squamous cell ...

A generic version of ibrutinib was granted tentative approval by the FDA for use in CLL and SLL with 17p deletion and ...

ICE-T Conference presenters explain what nurses and APPs should take into account as immune cell effector therapies become ...

Paolo Tarantino, MD, PhD, explains that the chemotherapy-related toxicities from an ADC are more likely to limit dosage for ...